The history and structure of MI services in the UK largely reflect those of the NHS in which it functions, and to which most of its activities are directed.
History
The history and
structure of MI services in the UK largely reflect those of the NHS in which it
functions, and to which most of its activities are directed. Through the 1960s
hospital pharmacy was undergoing a radical change, especially with the
development of ward-based, patient-focused activities – clinical pharmacy. The
pharmacist’s traditional role of com-pounding and supply was being replaced by
the provision of prescribing advice to doctors and nurses, and information
provision directly to patients. The hospital pharmacist became the ward-based
expert on med-icines and therapeutics. However, this expansion of activity was
accompanied by a parallel demand for high-quality and reliable information.
Prior to this, information on medicines was acquired from personal knowledge or
from standard reference sources. The requirement for information and advisory
support to healthcare professionals with a medicines-related role was further
stimulated by a number of simulta-neous developments. The so-called therapeutic
explosion in the 1960s and 1970s made available a vast array of new and potent
medicines with increased efficacy and toxicity. Accompanying this was an
‘information explosion’ in which the availability of published, critically
assessed, clinical information and evidence increased dramatically. This
literature covered all aspects of medicines, including their pharmacology,
pharma-cokinetics, comparative clinical efficacy, toxicity, use in specific
circum-stances such as pregnancy, and the pharmaceutics of formulation and drug
delivery. It is estimated that there are currently over 18 000 medical and
pharmaceutical journals worldwide, the majority of which have the poten-tial to
include information on medicines, although many are not peer-reviewed nor of
high quality. Of these only about 5400 are cited by Medline and 7000 by Embase
(these data sources are discussed later). The establishment of these new roles
for hospital pharmacists in the UK, including MI services, was formalised in
the Noel Hall report.
The demand for
high-quality, evaluated, rapidly available, patient-oriented information, that
was not from pharma industry, for all members of the healthcare team led to the
development of drug information services, which were renamed MI services in the
UK in 2000, to reflect better current terminology and links to medicines
management.
Related Topics
TH 2019 - 2025 pharmacy180.com; Developed by Therithal info.